Produkty 27833-18-7

CAS 27833-18-7 występuje w naszej ofercie pod nazwami: 17Alpha-Boldenone (1.0 mg/ml in Acetonitrile), 17alpha-Boldenone, >95% (HPLC), 17alpha-Boldenone, 17alpha-Boldenone 100 µg/mL in Acetonitrile. Oferty producentów: TRC, Dr. Ehrenstorfer. Dostępne opakowania: 1x1ml, 100mg, 10mg, 1ml.

17Alpha-Boldenone (1.0 mg/ml in Acetonitrile)
TRC
  • opakowanie: 1x1ml
  • Warianty: 1
Zobacz produkt
17alpha-Boldenone, >95% (HPLC)
TRC
  • opakowanie: 100mg, 10mg
  • Warianty: 2
Zobacz produkt
17alpha-Boldenone
Dr. Ehrenstorfer
  • opakowanie: 10mg
  • Warianty: 1
Zobacz produkt
17alpha-Boldenone 100 µg/mL in Acetonitrile
Dr. Ehrenstorfer
  • opakowanie: 1ml
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one (CAS 27833-18-7) to związek chemiczny o wzorze sumarycznym C19H26O2 i masie molowej 286.4 g/mol. Nazwa systematyczna IUPAC: (8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one. InChIKey: RSIHSRDYCUFFLA-KZYORJDKSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H26O2
Masa molowa286.4 g/mol
Nazwa IUPAC(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
InChIKeyRSIHSRDYCUFFLA-KZYORJDKSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@H]2O)CCC4=CC(=O)C=C[C@]34C

Dane obliczone przez PubChem (NCBI)

Synonimy: Epiboldenone, 17alpha-boldenone, Testosterone Impurity N35, 17alpha-Hydroxyandrosta-1,4-dien-3-one, 17alpha-Boldenone Solution in Acetonitrile, 100ug/mL, 17alpha-Boldenone Solution in Acetonitrile, 1000ug/mL
Powiązane formy tego związku
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C19H26O2
(8R,9S,10R,13S,14S,17S)-16,16,17-trideuterio-17-hydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-one C19H26O2
Izomery (ten sam wzór sumaryczny)
(10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C19H26O2
(8R,9S,13S,14S,17S)-2,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol C19H26O2
(8S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C19H26O2
(6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol C19H26O2
2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol C19H26O2
(8R,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-ol C19H26O2
(8R,9S,10R,13S,14S)-13-ethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione C19H26O2
(3S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-one C19H26O2
(3S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-one C19H26O2
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C19H26O2